90 likes | 254 Views
Industry analysis specialist GlobalData has released its latest report “Healthcare, Regulatory and Reimbursement Landscape - Belgium”. An essential source of information and analysis on the Belgian healthcare, regulatory and reimbursement landscape, it identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, and reimbursement landscape and healthcare infrastructure.
E N D
Healthcare, Regulatory and Reimbursement Landscape - Belgium Bharat Book Bureau
Summary • Industry analysis specialist GlobalData has released its latest report “Healthcare, Regulatory and Reimbursement Landscape - Belgium”. An essential source of information and analysis on the Belgian healthcare, regulatory and reimbursement landscape, it identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, and reimbursement landscape and healthcare infrastructure. • Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research and in-house analysis by team of industry experts.
Continue… • In 2012, Belgium had a population of 11 million. The pharmaceutical market was estimated to be worth $6.32 billion in 2013 at consumer-price level (including Value Added Tax (VAT) and excluding hospital sales) and is expected to reach $6.77 billion by 2020 at a projected Compound Annual Growth Rate (CAGR) of 0.98%. The medical device market was worth approximately $2.44 billion in 2013 and is expected to reach $3.41 billion by 2020 at a CAGR of 4.9%. • These positive trends can primarily be attributed to - - R&D investment- A conducive regulatory environment- Fast approval process and high-quality research, which attract companies wanting to conduct clinical trials- Increasing burden of elderly care- High per-capita healthcare expenditure
Continue… • These positive trends can primarily be attributed to - - R&D investment- A conducive regulatory environment- Fast approval process and high-quality research, which attract companies wanting to conduct clinical trials- Increasing burden of elderly care- High per-capita healthcare expenditure • Scope :-- The report provides information on the Belgian healthcare, regulatory and reimbursement landscape, including - Overview of the pharmaceutical and medical device markets, including size, segmentation, and key drivers and barriers
Continue… • Profiles and SWOT analyses of the major players in the pharmaceutical and medical device markets, namely Janssen Pharmaceutical, GlaxoSmithKline, Novartis, UCB, and Ablynx; and Siemens Healthcare, Medtronic, F. Hoffmann-La Roche, Abbott Laboratories, and Essilor International- Insightful review of the reimbursement and regulatory landscape, with details of the reimbursement process, regulatory agencies and market authorization processes for new drug and medical devices- Detailed analysis of the Belgian political and economic environment, including economic indicators, demographics, healthcare infrastructure and healthcare expenditure- An overview of the opportunities for and challenges to growth in the Belgian healthcare marke
Continue… Reasons to buy Develop business strategies by understanding the trends shaping and driving the healthcare marketDrive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical and medical devices market segments and companies likely to impact the healthcare market in the futureFormulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitorsOrganize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment and strategic partnershipsIdentify, understand and capitalize on the opportunities and challenges in the healthcare market
Table Of Contents 1 Table of Contents 51.1 List of Tables 71.2 List of Figures 92 Introduction 112.1 Report Guidance 113 Overview of the Pharmaceutical and Medical Device Markets 123.1 Pharmaceutical Market 123.1.1 Market Overview 123.1.2 Pharmaceutical Imports and Exports 153.1.3 Supply Channels 163.1.4 Market Segments 173.1.5 Major Therapeutic Areas 203.1.6 Major Players 223.2 Medical Device Market 503.2.1 Market Overview 503.2.2 Overview of Top Five Segments 523.2.3 Diagnostic Device Market 633.2.4 Major Players 65
Continue… 3.3 Market Drivers and Barriers 843.3.1 Drivers 843.3.2 Barriers 864 Market Access 884.1 Reimbursement and Payer Landscape 884.1.1 Overview of Healthcare System 884.1.2 Reimbursement Process 974.1.3 Overview of Insurance Providers 1084.1.4 Patients Share in Healthcare Spending 1124.1.5 Healthcare Price Trends 1134.1.6 Pricing Policies 1144.2 Regulatory Landscape 1154.2.1 Overview of Regulatory Agencies 1154.2.2 Market Authorization Procedure for Pharmaceutical Products 1204.2.3 New Medical Device Approval Process 1344.2.4 Licensing Process for Pharmaceutical and Medical Device Manufacturing 139
For More Information You Can Visit- http://www.bharatbook.com/healthcare-market-research-reports/healthcare-regulatory-and-reimbursement-landscape-belgium.html Or visit us at: Bharat Book BureauPhone : +91 22 27810772, 27810773 Fax : +91 22 27812290 Toll Free No for USA/Canada : 1-866-279-8368 E-mail : info@bharatbook.com Website : www.bharatbook.comTwitter:https://twitter.com/BharatBookBlog:http://blog.bharatbook.com/